Profound neutrophilia as the presenting sign of GCSF-secreting, ROS1-mutant squamous cell lung cancer

This is a case of squamous cell cancer (SCC) of the lung masquerading as a haematologic malignancy with marked neutrophilia ultimately found to have a <i>ROS1</i> rearrangement in a non-smoker patient. The patient achieved a near complete response to therapy and prompt resolution of neutrophilia after being started on a c-ros oncogene 1 (ROS1)-targeted tyrosine kinase inhibitor. Profound neutrophilia can be a presenting sign of granulocyte colony-stimulating factor (G-CSF) secreting SCC of the lung. This is significant because G-CSF can potentially masquerade as alternative diagnoses, delaying appropriate treatment. Neutrophilia may also be a potential tool for disease monitoring in such cases. Furthermore, this case describes a rare presentation of a ROS1 alteration in SCC of the lung. This illustrates the importance of routine comprehensive genomic profiling in lung cancer patients regardless of histology and smoking status.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-12-01
DOI
https://doi.org/10.1136/bcr-2025-267778
Primary Topic
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Profound neutrophilia as the presenting sign of GCSF-secreting, ROS1-mutant squamous cell lung cancer

Adam Rock, Akanksha Dua, S. Garg
BMJ Case Reports
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
article

Profound neutrophilia as the presenting sign of GCSF-secreting, ROS1-mutant squamous cell lung cancer

Adam Rock, Akanksha Dua, S. Garg
article en

Abstract

This is a case of squamous cell cancer (SCC) of the lung masquerading as a haematologic malignancy with marked neutrophilia ultimately found to have a <i>ROS1</i> rearrangement in a non-smoker patient. The patient achieved a near complete response to therapy and prompt resolution of neutrophilia after being started on a c-ros oncogene 1 (ROS1)-targeted tyrosine kinase inhibitor. Profound neutrophilia can be a presenting sign of granulocyte colony-stimulating factor (G-CSF) secreting SCC of the lung. This is significant because G-CSF can potentially masquerade as alternative diagnoses, delaying appropriate treatment. Neutrophilia may also be a potential tool for disease monitoring in such cases. Furthermore, this case describes a rare presentation of a ROS1 alteration in SCC of the lung. This illustrates the importance of routine comprehensive genomic profiling in lung cancer patients regardless of histology and smoking status.

BMJ Case ReportsVol. 18(12)
City Of Hope National Medical Center (US), Anne Arundel Medical Center (US), City of Hope (US)
Openalex Percentile: Top 57%
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Profound neutrophilia as the presenting sign of GCSF-secreting, ROS1-mutant squamous cell lung cancer — Adam Rock, Akanksha Dua, et al. · BMJ Case Reports (2025) | TGRS Research Map | TGRS